“Pre-Diabetes” Screening Coverage Could Find Congressional Support
This article was originally published in The Gray Sheet
Executive Summary
Recent legislation directing Medicare to cover expanded glaucoma and cancer screening establishes a precedent for covering individuals at high risk of Type 2 diabetes
You may also be interested in...
Medicare Giveback Package Includes $1.5 Bil. For Screening Initiatives
Increasing Medicare payments for bilateral diagnostic mammography using new technologies to 150% of the current physician fee is scored as costing $400 mil. over five years.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.